Evidence map›Paper›PMID 25400812›Full record

ArticleInternational journal of clinical and experimental pathology2014

Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.

Wenjian Yao, Xiuguang Qin, Bo Qi, Jianguo Lu, Ling Guo, Fulei Liu, Shangguo Liu, Baosheng Zhao

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Investigation on the Potential Correlation BetweenFrontiers in cell and developmental biology · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Prognostic value ofOncoTargets and therapy · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenjian YaoDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Xiuguang QinDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Bo QiDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Jianguo LuDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Ling GuoDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Fulei LiuDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Shangguo LiuDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.
Baosheng ZhaoDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University 88 Jiankang Road, Weihui, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been well accepted that p53 overexpression is associated with advanced stages of cancer. However, the prognostic role of p53 overexpression in esophageal squamous cell carcinoma (ESCC) remains unclear. To investigate the prognostic role of p53 overexpression in patients with ESCC, a retrospective cohort study of 136 ESCC patients was carried out. The expression of p53 protein in tumor tissues was investigated immunohistochemically. Positive expression of p53 protein was detected in 57 ESCC patients (41.9%). The p53 overexpression was associated with smoking (P < 0.001), tumor differentiation (P < 0.001), and tumor size (P < 0.001). In the Kaplan-Meier analysis, patients with p53 overexpression had significantly shorter overall survival than those patients with negative p53 expression (log-rank P < 0.001). Multivariable analysis by Cox regression model further showed that p53 overexpression was a significantly independent predictor of poorer overall survival (hazard ratio [HR] = 1.91; 95% confidence interval [95% CI] 1.03-3.54, P = 0.04). Thus, p53 overexpression is associated with poor prognosis in patients with early stage esophageal squamous cell carcinoma, and it's a significantly independent predictor of poorer overall survival.

Indexed as

AdultAgedBiomarkers, TumorCarcinoma, Squamous CellCell DifferentiationChi-Square DistributionEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleHumansImmunohistochemistryKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoplasm StagingBiomarkers, TumorTP53 protein, humanTumor Suppressor Protein p53Esophageal squamous cell carcinomap53survival

Identifiers

PMID25400812
PMCPMC4230131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.